IV Contrast
Showing 1 - 25 of >10,000
Transcatheter Aortic Valve Replacement Trial in Baltimore (Iodinated Contrast Agent (Omnipaque), Dual Energy CT)
Not yet recruiting
- Transcatheter Aortic Valve Replacement
- Iodinated Contrast Agent (Omnipaque)
- Dual Energy CT
-
Baltimore, MarylandUniversity of Maryland Medical Center
Feb 24, 2023
Acute Flank Pain Trial in Taipei (Ultrasound with IV contrast, CT with IV contrast, Ultrasound without IV contrast)
Not yet recruiting
- Acute Flank Pain
- Ultrasound with IV contrast
- +3 more
-
Taipei, TaiwanTaipei City Hospital Zhong-Xing branch
May 7, 2021
Pelvic Cancer, Abdominal Cancer Trial in New York (Omnipaque 300mg/mL Solution for Injection, Cone Beam CT, Radiation Therapy)
Recruiting
- Pelvic Cancer
- Abdominal Cancer
- Omnipaque 300mg/mL Solution for Injection
- +3 more
-
New York, New YorkColumbia University Irving Medical Center/Department of Radiatio
Mar 7, 2022
Contrast-induced Acute Kidney Injury, Acute Coronary Syndromes Trial in Milan, Naples (Coronary angiography using DyeVert
Recruiting
- Contrast-induced Acute Kidney Injury
- Acute Coronary Syndromes
- Coronary angiography using DyeVert system
- Coronary angiography using conventional manual injection syringe.
-
Milan, Italy
- +1 more
Dec 16, 2021
GI Carcinoma, GI Disorders Trial in Rochester, Seattle (NX9 Oral Contrast Agent)
Completed
- GI Carcinoma
- GI Disorders
- NX9 Oral Contrast Agent
-
Rochester, Minnesota
- +1 more
Jan 13, 2022
Contrast-induced Nephropathy, Kidney Injury, Kidney Failure, Chronic Trial in Odense C (Kidney prophylaxis with IV-hydration,
Recruiting
- Contrast-induced Nephropathy
- +3 more
- Kidney prophylaxis with IV-hydration
- Kidney prophylaxis with oral hydration
-
Odense C, Fyn, DenmarkDepartment of Cardiology
Oct 31, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +12 more
- Computed Tomography
- Contrast Agent
-
New Brunswick, New Jersey
- +1 more
Nov 2, 2022
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin
Completed
- Stage I Renal Cell Cancer
- +3 more
- Arterial Spin Labeling Magnetic Resonance Imaging
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 14, 2022
Called UV Population, to Learn More About Safety of Study Drug
Recruiting
- Contrast Enhanced X-ray Based Examination
- Iopromide (Ultravist, BAY86-4877)
-
Multiple Locations, GermanyMany Locations
Jul 26, 2022
Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC
Recruiting
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- +7 more
- Gemcitabine Hydrochloride
- +8 more
-
Philadelphia, Pennsylvania
- +1 more
Dec 20, 2022
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
Myocardial Fibrosis Associated With Monocyte Phenotype in End
Withdrawn
- Myocardial Fibrosis
- +4 more
- Cardiac MRI 1 - With Gadolinium Contrast
- +4 more
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 30, 2021
Brain Lesions Trial in Charleston (Contrast)
Completed
- Brain Lesions
- Contrast
-
Charleston, South CarolinaMedical University of South Carolina
Jan 29, 2021
Head and Neck Tumors Trial in Toronto (Pre-op CTA with IV contrast, Computed tomography angiography (CTA))
Terminated
- Head and Neck Neoplasms
- Pre-op CTA with IV contrast
- Computed tomography angiography (CTA)
-
Toronto, Ontario, CanadaUniversity Health Network
Dec 14, 2020
Pain Trial in Brooklyn (Preservative Free Lidocaine, Saline)
Recruiting
- Pain
- Preservative Free Lidocaine
- Saline
-
Brooklyn, New YorkMaimonides Medical Center
Jan 31, 2023
Multiple Sclerosis Trial in Worldwide (SAR441344 IV, IV, SAR441344 SC)
Active, not recruiting
- Multiple Sclerosis
- SAR441344 IV
- +4 more
-
Phoenix, Arizona
- +47 more
Oct 10, 2022
Microwave Ablation or Wedge Resection for Treatment of Lung,
Recruiting
- Lung Non-Small Cell Carcinoma
- +21 more
- Computed Tomography with Contrast
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 10, 2020
Breast Cancer, Postsurgical Acquired Absence of Organ Trial in Moscow (Non-contrast MRA in preoperative perforator vessels
Recruiting
- Breast Cancer
- Postsurgical Acquired Absence of Organ
- Non-contrast MRA in preoperative perforator vessels mapping for deep inferior epigastric perforator (DIEP) flap breast reconstruction planning.
- CTA with iodine contrast in preoperative perforator vessels mapping for deep inferior epigastric perforator (DIEP) flap breast reconstruction planning.
-
Moscow, Russian Federation
- +1 more
Sep 25, 2023
Kidney Failure, Chronic, Kidney Failure, Acute, Heart Failure Trial in Madrid (Oral sodium chloride, Intravenous sodium
Completed
- Kidney Failure, Chronic
- +3 more
- Oral sodium chloride
- Intravenous sodium chloride
-
Madrid, SpainHospital Universitario Ramon y Cajal
Mar 2, 2020
The Discrepancy in Radiologists' Practice of Intravenous
Completed
- Chronic Kidney Diseases
- Chronic Kidney Disease 5D
- Questionnare
-
Banhā, Qalubia, EgyptBenha Faculty of Medicine
Feb 6, 2023
Contrast Induced Nephropathy Trial in Miami Beach (Intravenous Nitroglycerin, IV Fluids)
Completed
- Contrast Induced Nephropathy
- Intravenous Nitroglycerin
- IV Fluids
-
Miami Beach, FloridaMount Sinai Medical Center
Oct 11, 2019
Emergent Prep for IV Dye in Acute Stroke Patients With Allergy
Enrolling by invitation
- Stroke
- Dye Allergy
- Emergent IV Dye Preparation
-
Philadelphia, Pennsylvania(unnamed)
Jun 7, 2023
Emergency Patients New Markers of Kidney Function in ED Patients
Withdrawn
- Acute Kidney Injury
- Contrast Media
-
Regensburg, Bavaria, GermanyKrankenhaus Barmherzige Brueder
Aug 18, 2022
Breast Carcinoma Trial in Houston (procedure, drug, other)
Recruiting
- Breast Carcinoma
- Contrast Enhanced Digital Mammography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2022